跳至主要内容
临床试验/IRCT20200919048757N1
IRCT20200919048757N1尚未招募3 期

Effects of Chromium Picolinate on Glycemic Index,Lipid Profile ?Gene Expression of Inflammatory Biomarkers and DNA damage in Metabolic Syndrome Patients

Yazd University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Metabolic syndrome characterized byat least three of the five conditions: - waist circumference =94 cm - systolic blood pressure and diastolic greater than or equal to 130 and 85 mm Hg respectively or blood pressure lowering medication use - Fasting Blood Sugar= 100 mg / dl or hypoglycemic drugs use - Blood triglycerides =150 mg / dl or lipid-lowering drugs use - HDL<50mg/dl in women and less than 40 mg/ dl in Men

排除标准

  • take any multivitamins or dietary supplements or medications
  • Pregnancy or lactation
  • uncontrolled hypertension or hyperglycemia
  • chronic obstructive pulmonary disease
  • heart arrhythmias
  • any other disease that requires medical treatment

研究者

发起方
Yazd University of Medical Sciences

相似试验